Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment
Antitumor therapy with CD19-targeted chimeric antigen receptor (CAR) modified T cells is highly efficient. However, treatment is often complicated by a unique profile of unpredictable neurotoxic adverse effects of varying degrees known as immune effector cell-associated neurotoxicity syndrome (ICANS...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
May 17, 2022
|
| In: |
Blood advances
Year: 2022, Jahrgang: 6, Heft: 10, Pages: 3022-3026 |
| ISSN: | 2473-9537 |
| DOI: | 10.1182/bloodadvances.2021006144 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/bloodadvances.2021006144
|
| Verfasserangaben: | Florian Schoeberl, Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, Vanessa Granja Burbano, Veit L. Bücklein, Kai Rejeski, Christian Schmidt, Galina Busch, Michael von Bergwelt-Baildon, Jörg-Christian Tonn, Michael Schmitt, Marion Subklewe, and Louisa von Baumgarten |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1815083182 | ||
| 003 | DE-627 | ||
| 005 | 20230118152627.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220824s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/bloodadvances.2021006144 |2 doi | |
| 035 | |a (DE-627)1815083182 | ||
| 035 | |a (DE-599)KXP1815083182 | ||
| 035 | |a (OCoLC)1361713122 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schöberl, Florian |d 1982- |e VerfasserIn |0 (DE-588)143707965 |0 (DE-627)655893555 |0 (DE-576)339566523 |4 aut | |
| 245 | 1 | 0 | |a Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment |c Florian Schoeberl, Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, Vanessa Granja Burbano, Veit L. Bücklein, Kai Rejeski, Christian Schmidt, Galina Busch, Michael von Bergwelt-Baildon, Jörg-Christian Tonn, Michael Schmitt, Marion Subklewe, and Louisa von Baumgarten |
| 264 | 1 | |c May 17, 2022 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.08.2022 | ||
| 520 | |a Antitumor therapy with CD19-targeted chimeric antigen receptor (CAR) modified T cells is highly efficient. However, treatment is often complicated by a unique profile of unpredictable neurotoxic adverse effects of varying degrees known as immune effector cell-associated neurotoxicity syndrome (ICANS). We examined 96 patients receiving CAR T cells for refractory B-cell malignancies at 2 major CAR T-cell treatment centers to determine whether serum levels of neurofilament light chain (NfL), a marker of neuroaxonal injury, correlate with the severity of ICANS. Serum NfL levels were measured before and after infusion of CAR T cells using a single-molecule enzyme-linked immunosorbent assay and correlated with the severity of ICANS. Elevated NfL serum levels before treatment were associated with more severe ICANS in both unadjusted and adjusted analyses. Multivariable statistical models revealed a significant increase in NfL levels after CAR T-cell infusion, which correlated with the severity of ICANS. Preexisting neuroaxonal injury. which was characterized by higher NfL levels before CAR T-cell treatment, correlated with the severity of subsequent ICANS. Thus, serum NfL level might serve as a predictive biomarker for assessing the severity of ICANS and for improving patient monitoring after CAR T-cell transfusion. However, these preliminary results should be validated in a larger prospective cohort of patients. | ||
| 700 | 1 | |a Tiedt, Steffen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmitt, Anita |d 1969- |e VerfasserIn |0 (DE-588)141722495 |0 (DE-627)630587752 |0 (DE-576)325593892 |4 aut | |
| 700 | 1 | |a Blumenberg, Viktoria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Karschnia, Philipp |e VerfasserIn |4 aut | |
| 700 | 1 | |a Burbano, Vanessa Granja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bücklein, Veit Leonhard |d 1981- |e VerfasserIn |0 (DE-588)1036716813 |0 (DE-627)751024023 |0 (DE-576)385349726 |4 aut | |
| 700 | 1 | |a Rejeski, Kai |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmidt, Christian |e VerfasserIn |0 (DE-588)1270081217 |0 (DE-627)1818794675 |4 aut | |
| 700 | 1 | |a Busch, Galina |e VerfasserIn |4 aut | |
| 700 | 1 | |a von Bergwelt-Baildon, Michael |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tonn, Jörg-Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmitt, Michael |d 1966- |e VerfasserIn |0 (DE-588)133177173 |0 (DE-627)538000600 |0 (DE-576)299672921 |4 aut | |
| 700 | 1 | |a Subklewe, Marion |d 1967- |e VerfasserIn |0 (DE-588)113820887 |0 (DE-627)567059200 |0 (DE-576)28977599X |4 aut | |
| 700 | 1 | |a Baumgarten, Louisa von |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood advances |d Washington, DC : American Society of Hematology, 2016 |g 6(2022), 10, Seite 3022-3026 |h Online-Ressource |w (DE-627)873588312 |w (DE-600)2876449-3 |w (DE-576)48043249X |x 2473-9537 |7 nnas |a Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment |
| 773 | 1 | 8 | |g volume:6 |g year:2022 |g number:10 |g pages:3022-3026 |g extent:5 |a Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment |
| 856 | 4 | 0 | |u https://doi.org/10.1182/bloodadvances.2021006144 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220824 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 133177173 |a Schmitt, Michael |m 133177173:Schmitt, Michael |d 910000 |d 910100 |e 910000PS133177173 |e 910100PS133177173 |k 0/910000/ |k 1/910000/910100/ |p 13 | ||
| 998 | |g 141722495 |a Schmitt, Anita |m 141722495:Schmitt, Anita |d 910000 |d 910100 |d 50000 |e 910000PS141722495 |e 910100PS141722495 |e 50000PS141722495 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 3 | ||
| 999 | |a KXP-PPN1815083182 |e 4182392027 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"5 S."}],"note":["Gesehen am 24.08.2022"],"recId":"1815083182","id":{"eki":["1815083182"],"doi":["10.1182/bloodadvances.2021006144"]},"relHost":[{"language":["eng"],"origin":[{"publisher":"American Society of Hematology","publisherPlace":"Washington, DC","dateIssuedDisp":"[2016]-"}],"pubHistory":["Vol. 1, iss. 1 (November 2016)-"],"name":{"displayForm":["American Society of Hematology"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title":"Blood advances","title_sort":"Blood advances"}],"part":{"volume":"6","text":"6(2022), 10, Seite 3022-3026","pages":"3022-3026","issue":"10","extent":"5","year":"2022"},"disp":"Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatmentBlood advances","id":{"eki":["873588312"],"issn":["2473-9537"],"zdb":["2876449-3"]},"recId":"873588312","note":["Gesehen am 27.04.21"],"physDesc":[{"extent":"Online-Ressource"}]}],"title":[{"title":"Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment","title_sort":"Neurofilament light chain serum levels correlate with the severity of neurotoxicity after CAR T-cell treatment"}],"person":[{"family":"Schöberl","display":"Schöberl, Florian","role":"aut","given":"Florian"},{"display":"Tiedt, Steffen","role":"aut","given":"Steffen","family":"Tiedt"},{"family":"Schmitt","role":"aut","given":"Anita","display":"Schmitt, Anita"},{"family":"Blumenberg","display":"Blumenberg, Viktoria","role":"aut","given":"Viktoria"},{"family":"Karschnia","display":"Karschnia, Philipp","role":"aut","given":"Philipp"},{"display":"Burbano, Vanessa Granja","role":"aut","given":"Vanessa Granja","family":"Burbano"},{"family":"Bücklein","display":"Bücklein, Veit Leonhard","given":"Veit Leonhard","role":"aut"},{"role":"aut","given":"Kai","display":"Rejeski, Kai","family":"Rejeski"},{"family":"Schmidt","given":"Christian","role":"aut","display":"Schmidt, Christian"},{"family":"Busch","display":"Busch, Galina","role":"aut","given":"Galina"},{"given":"Michael","role":"aut","display":"von Bergwelt-Baildon, Michael","family":"von Bergwelt-Baildon"},{"family":"Tonn","display":"Tonn, Jörg-Christian","given":"Jörg-Christian","role":"aut"},{"role":"aut","given":"Michael","display":"Schmitt, Michael","family":"Schmitt"},{"display":"Subklewe, Marion","given":"Marion","role":"aut","family":"Subklewe"},{"role":"aut","given":"Louisa von","display":"Baumgarten, Louisa von","family":"Baumgarten"}],"language":["eng"],"name":{"displayForm":["Florian Schoeberl, Steffen Tiedt, Anita Schmitt, Viktoria Blumenberg, Philipp Karschnia, Vanessa Granja Burbano, Veit L. Bücklein, Kai Rejeski, Christian Schmidt, Galina Busch, Michael von Bergwelt-Baildon, Jörg-Christian Tonn, Michael Schmitt, Marion Subklewe, and Louisa von Baumgarten"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"May 17, 2022","dateIssuedKey":"2022"}]} | ||
| SRT | |a SCHOEBERLFNEUROFILAM1720 | ||